PSMD14 is a novel prognostic marker and therapeutic target in osteosarcoma
Abstract Background Osteosarcoma is a bone tumor that is characterized by high malignancy and a high mortality rate, and that originates from primitive osteoblastic mesenchymal cells and is most common in rapidly growing long bones. PSMD14, also known as RPN11 or POH1, is a member of the JAMM isopep...
Saved in:
Main Authors: | Jiabin Lai (Author), Weike Kong (Author), Qiangchang Fu (Author), Zhaochang Jiang (Author), Bohao Sun (Author), Xin Ye (Author), Jing Kong (Author), Shumei Wei (Author), Lifeng Jiang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation
by: Hongyuan Jiang, et al.
Published: (2024) -
OVEREXPRESSION OF IGF1 PROGNOSTIC FACTOR IN CHILDHOOD OSTEOSARCOMAS
by: A. Ivan, et al.
Published: (2024) -
Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
by: Yibo Ma, et al.
Published: (2023) -
lncRNA MELTF-AS1 facilitates osteosarcoma metastasis by modulating MMP14 expression
by: Lei Ding, et al.
Published: (2021) -
Correlation between family support with work productivity of people with severe mental disorders (PSMD) in Bantur Community Health Center, Malang, Indonesia
by: Renny Nova, et al.
Published: (2023)